z-logo
open-access-imgOpen Access
Spectrum of Haematological Abnormalities in Patients of Multiple Myeloma
Author(s) -
Kiran Aamir,
Muhammad Hanif,
Hina Abbas,
Aamir Ramzan
Publication year - 2020
Publication title -
journal of saidu medical college
Language(s) - English
Resource type - Journals
ISSN - 1819-4583
DOI - 10.52206/jsmc.2020.10.1.271
Subject(s) - multiple myeloma , medicine , plasma cell dyscrasia , anemia , bone marrow , gastroenterology , dyscrasia , leukopenia , plasma cell , malignancy , plasmacytosis , immunology , chemotherapy , immunoglobulin light chain , antibody
Background: Multiple myeloma is plasma cell dyscrasia characterized by uncontrolled proliferation of plasma cells and adistinctive biological behavior. It is an uncommon hematological malignancy which primarily affects older individuals.Objective: To determine clinico-hematological profile of Multiple Myeloma patients.Material and Methods: It is a retrospective study conducted at a tertiary care hospital for a period of 6 month in which 55 patientsdiagnosed as Multiple myeloma were enrolled. Data of 55 cases of multiple myeloma was analyzed.Results: Fifty five confirmed cases of MM were identified. There were 44 male and 11 female with a male to female ratio of 2:1. Thefrequency of multiple myeloma was high in patients with age 60-69 years. The median age of all patients was 56yrs (range 34-75).Anemia was present in 96.3% of patients 51% showed thrombocytopenia and 15% showed leucopenia. 91% of patients had ESRvalues above 80mm/hr. Serum of 93% patients showed M.band in SPE. Bone marrow of 45.4% patients had 11-20% plasma cells,marrow of 20% of patients contain 21-60% cells while that of 34.5% patients contain > 60% plasma cells. It was observed thatsome of those patients with plasma cells >60% showed severe anemia, severe thrombocytopenia and severe leucopenia.Radiographic examination showed lytic lesions in all patientsConclusions: Our analysis shows that clinico-pathological features of multiple myeloma patients in Pakistan are comparable topublished data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here